Physician profile
Kevin Lutta
NPI 1902063092
$26,062.86
in general payments reported to CMS, 2019-2025
30 companies · $12K in 2025
The $12K reported for 2025 was more than what 80% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,655 · 2020: $672 · 2021: $261 · 2022: $1,545 · 2023: $6,258 · 2024: $3,567 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $14K · Consulting Fee: $4,500 · Food and Beverage: $3,034 · Travel and Lodging: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $13,784.27 |
| Consulting Fee | $4,500.00 |
| Food and Beverage | $3,033.78 |
| Travel and Lodging | $612.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glw, INC | $13,784.27 | 2024-2025 | Apollo |
| Novastep INC. | $5,392.37 | 2022-2023 | Airlock Forefoot/Midfoot Plating, Peca Bunion Correction System |
| International Life Sciences | $1,212.25 | 2023 | |
| Stryker Corporation | $1,021.82 | 2019-2025 | Prophecy, Alphavent, Pangea |
| Wright Medical Technology, INC. | $961.22 | 2019-2020 | |
| Supreme Orthopedic Systems, LLC | $815.79 | 2022-2025 | |
| Smith+Nephew, INC. | $474.55 | 2019-2025 | Q-Fix, Bone Anchors With Arthroscopic Delivery System, Stravix |
| Exactech, INC. | $454.46 | 2020-2021 | |
| Arteriocyte Medical Systems, INC. | $383.50 | 2019-2024 | Magellan |
| Flower Orthopedics Coporation | $226.41 | 2023-2024 | |
| Linvatec Corporation | $163.05 | 2022-2025 | Allograft Tissue, Hercules Suture Anchor System, Biobrace 23mm |
| Paragon 28, INC. | $120.17 | 2022 | |
| Molnlycke Health Care US, LLC | $109.79 | 2022 | |
| Depuy Synthes Sales INC. | $97.84 | 2019-2025 | Monovisc, Peak, Orthovisc |
| Medshape, INC. | $93.00 | 2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $87.92 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ossio INC | $87.67 | 2022 | |
| Biocomposites INC | $83.20 | 2024 | |
| Horizon Therapeutics Plc | $78.44 | 2019 | |
| Acumed LLC | $78.30 | 2023-2024 | Acumed, Osteomed |
| Trilliant Surgical LLC. | $65.18 | 2025 | Arsenal Sinus Support Plate |
| Zimmer Biomet Holdings, INC. | $59.93 | 2019-2024 | |
| Bone Support INC. | $44.52 | 2024 | Cerament G, Ceramentbone Void Filler |
| Pacira Pharmaceuticals Incorporated | $37.50 | 2019-2023 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $36.81 | 2019 | |
| Heron Therapeutics, INC. | $28.68 | 2024 | Zynrelef |
| Amgen INC. | $25.88 | 2025 | Krystexxa |
| Misonix INC | $19.42 | 2019 | |
| Pacira Therapeutics, INC. | $15.75 | 2019 | |
| Orthofix Medical, INC. | $3.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Lutta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.